Kenneth M. Verburg

机构：Pfizer (United States)

发表论文 106 篇 · 总被引 10708 次 · h-index 40

代表论文

• Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee (2019 · JAMA · 被引 205)
• Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period (2020 · Annals of the Rheumatic Diseases · 被引 174)
• Long‐Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial (2021 · Arthritis & Rheumatology · 被引 83)
• Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety (2020 · Pain · 被引 62)
• Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendations (2021 · Pain · 被引 54)
• Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis (2018 · Journal of Pain Research · 被引 40)